Global Biosimilars Drug Market Research Report 2024, Forecast to 2032
Report Overview
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global Biosimilars Drug market size was estimated at USD 2830 million in 2023 and is projected to reach USD 21237.44 million by 2032, exhibiting a CAGR of 25.10% during the forecast period.
North America Biosimilars Drug market size was estimated at USD 1088.85 million in 2023, at a CAGR of 21.51% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Biosimilars Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilars Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilars Drug market in any manner.
Global Biosimilars Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Celltrion
Pfizer
Novartis
Dr Reddy’s
Celgen Biopharma
Eli Lilly
Sanofi
Geropharm
Biocon
Wockhardt
Market Segmentation (by Type)
Monoclonal Antibodies
Insulin
Others
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilars Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biosimilars Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global Biosimilars Drug market size was estimated at USD 2830 million in 2023 and is projected to reach USD 21237.44 million by 2032, exhibiting a CAGR of 25.10% during the forecast period.
North America Biosimilars Drug market size was estimated at USD 1088.85 million in 2023, at a CAGR of 21.51% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Biosimilars Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilars Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilars Drug market in any manner.
Global Biosimilars Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Celltrion
Pfizer
Novartis
Dr Reddy’s
Celgen Biopharma
Eli Lilly
Sanofi
Geropharm
Biocon
Wockhardt
Market Segmentation (by Type)
Monoclonal Antibodies
Insulin
Others
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biosimilars Drug Market
- Overview of the regional outlook of the Biosimilars Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilars Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biosimilars Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biosimilars Drug
1.2 Key Market Segments
1.2.1 Biosimilars Drug Segment by Type
1.2.2 Biosimilars Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOSIMILARS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biosimilars Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Biosimilars Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOSIMILARS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Biosimilars Drug Sales by Manufacturers (2019-2024)
3.2 Global Biosimilars Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biosimilars Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biosimilars Drug Sales Sites, Area Served, Product Type
3.6 Biosimilars Drug Market Competitive Situation and Trends
3.6.1 Biosimilars Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biosimilars Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOSIMILARS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Biosimilars Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOSIMILARS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOSIMILARS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biosimilars Drug Sales Market Share by Type (2019-2024)
6.3 Global Biosimilars Drug Market Size Market Share by Type (2019-2024)
6.4 Global Biosimilars Drug Price by Type (2019-2024)
7 BIOSIMILARS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biosimilars Drug Market Sales by Application (2019-2024)
7.3 Global Biosimilars Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Biosimilars Drug Sales Growth Rate by Application (2019-2024)
8 BIOSIMILARS DRUG MARKET CONSUMPTION BY REGION
8.1 Global Biosimilars Drug Sales by Region
8.1.1 Global Biosimilars Drug Sales by Region
8.1.2 Global Biosimilars Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Biosimilars Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biosimilars Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biosimilars Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biosimilars Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biosimilars Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 BIOSIMILARS DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Biosimilars Drug by Region (2019-2024)
9.2 Global Biosimilars Drug Revenue Market Share by Region (2019-2024)
9.3 Global Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Biosimilars Drug Production
9.4.1 North America Biosimilars Drug Production Growth Rate (2019-2024)
9.4.2 North America Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Biosimilars Drug Production
9.5.1 Europe Biosimilars Drug Production Growth Rate (2019-2024)
9.5.2 Europe Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Biosimilars Drug Production (2019-2024)
9.6.1 Japan Biosimilars Drug Production Growth Rate (2019-2024)
9.6.2 Japan Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Biosimilars Drug Production (2019-2024)
9.7.1 China Biosimilars Drug Production Growth Rate (2019-2024)
9.7.2 China Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Qilu Pharmaceutical
10.1.1 Qilu Pharmaceutical Biosimilars Drug Basic Information
10.1.2 Qilu Pharmaceutical Biosimilars Drug Product Overview
10.1.3 Qilu Pharmaceutical Biosimilars Drug Product Market Performance
10.1.4 Qilu Pharmaceutical Business Overview
10.1.5 Qilu Pharmaceutical Biosimilars Drug SWOT Analysis
10.1.6 Qilu Pharmaceutical Recent Developments
10.2 Bio-Thera
10.2.1 Bio-Thera Biosimilars Drug Basic Information
10.2.2 Bio-Thera Biosimilars Drug Product Overview
10.2.3 Bio-Thera Biosimilars Drug Product Market Performance
10.2.4 Bio-Thera Business Overview
10.2.5 Bio-Thera Biosimilars Drug SWOT Analysis
10.2.6 Bio-Thera Recent Developments
10.3 Zhejiang Hisun
10.3.1 Zhejiang Hisun Biosimilars Drug Basic Information
10.3.2 Zhejiang Hisun Biosimilars Drug Product Overview
10.3.3 Zhejiang Hisun Biosimilars Drug Product Market Performance
10.3.4 Zhejiang Hisun Biosimilars Drug SWOT Analysis
10.3.5 Zhejiang Hisun Business Overview
10.3.6 Zhejiang Hisun Recent Developments
10.4 Shanghai Henlius
10.4.1 Shanghai Henlius Biosimilars Drug Basic Information
10.4.2 Shanghai Henlius Biosimilars Drug Product Overview
10.4.3 Shanghai Henlius Biosimilars Drug Product Market Performance
10.4.4 Shanghai Henlius Business Overview
10.4.5 Shanghai Henlius Recent Developments
10.5 Innovent Biologics
10.5.1 Innovent Biologics Biosimilars Drug Basic Information
10.5.2 Innovent Biologics Biosimilars Drug Product Overview
10.5.3 Innovent Biologics Biosimilars Drug Product Market Performance
10.5.4 Innovent Biologics Business Overview
10.5.5 Innovent Biologics Recent Developments
10.6 Jiangsu Hengrui
10.6.1 Jiangsu Hengrui Biosimilars Drug Basic Information
10.6.2 Jiangsu Hengrui Biosimilars Drug Product Overview
10.6.3 Jiangsu Hengrui Biosimilars Drug Product Market Performance
10.6.4 Jiangsu Hengrui Business Overview
10.6.5 Jiangsu Hengrui Recent Developments
10.7 GanandLee
10.7.1 GanandLee Biosimilars Drug Basic Information
10.7.2 GanandLee Biosimilars Drug Product Overview
10.7.3 GanandLee Biosimilars Drug Product Market Performance
10.7.4 GanandLee Business Overview
10.7.5 GanandLee Recent Developments
10.8 Tonghua Dongbao
10.8.1 Tonghua Dongbao Biosimilars Drug Basic Information
10.8.2 Tonghua Dongbao Biosimilars Drug Product Overview
10.8.3 Tonghua Dongbao Biosimilars Drug Product Market Performance
10.8.4 Tonghua Dongbao Business Overview
10.8.5 Tonghua Dongbao Recent Developments
10.9 United Laboratory
10.9.1 United Laboratory Biosimilars Drug Basic Information
10.9.2 United Laboratory Biosimilars Drug Product Overview
10.9.3 United Laboratory Biosimilars Drug Product Market Performance
10.9.4 United Laboratory Business Overview
10.9.5 United Laboratory Recent Developments
10.10 3SBIO
10.10.1 3SBIO Biosimilars Drug Basic Information
10.10.2 3SBIO Biosimilars Drug Product Overview
10.10.3 3SBIO Biosimilars Drug Product Market Performance
10.10.4 3SBIO Business Overview
10.10.5 3SBIO Recent Developments
10.11 Luye Pharma
10.11.1 Luye Pharma Biosimilars Drug Basic Information
10.11.2 Luye Pharma Biosimilars Drug Product Overview
10.11.3 Luye Pharma Biosimilars Drug Product Market Performance
10.11.4 Luye Pharma Business Overview
10.11.5 Luye Pharma Recent Developments
10.12 Celltrion
10.12.1 Celltrion Biosimilars Drug Basic Information
10.12.2 Celltrion Biosimilars Drug Product Overview
10.12.3 Celltrion Biosimilars Drug Product Market Performance
10.12.4 Celltrion Business Overview
10.12.5 Celltrion Recent Developments
10.13 Pfizer
10.13.1 Pfizer Biosimilars Drug Basic Information
10.13.2 Pfizer Biosimilars Drug Product Overview
10.13.3 Pfizer Biosimilars Drug Product Market Performance
10.13.4 Pfizer Business Overview
10.13.5 Pfizer Recent Developments
10.14 Novartis
10.14.1 Novartis Biosimilars Drug Basic Information
10.14.2 Novartis Biosimilars Drug Product Overview
10.14.3 Novartis Biosimilars Drug Product Market Performance
10.14.4 Novartis Business Overview
10.14.5 Novartis Recent Developments
10.15 Dr Reddy’s
10.15.1 Dr Reddy’s Biosimilars Drug Basic Information
10.15.2 Dr Reddy’s Biosimilars Drug Product Overview
10.15.3 Dr Reddy’s Biosimilars Drug Product Market Performance
10.15.4 Dr Reddy’s Business Overview
10.15.5 Dr Reddy’s Recent Developments
10.16 Celgen Biopharma
10.16.1 Celgen Biopharma Biosimilars Drug Basic Information
10.16.2 Celgen Biopharma Biosimilars Drug Product Overview
10.16.3 Celgen Biopharma Biosimilars Drug Product Market Performance
10.16.4 Celgen Biopharma Business Overview
10.16.5 Celgen Biopharma Recent Developments
10.17 Eli Lilly
10.17.1 Eli Lilly Biosimilars Drug Basic Information
10.17.2 Eli Lilly Biosimilars Drug Product Overview
10.17.3 Eli Lilly Biosimilars Drug Product Market Performance
10.17.4 Eli Lilly Business Overview
10.17.5 Eli Lilly Recent Developments
10.18 Sanofi
10.18.1 Sanofi Biosimilars Drug Basic Information
10.18.2 Sanofi Biosimilars Drug Product Overview
10.18.3 Sanofi Biosimilars Drug Product Market Performance
10.18.4 Sanofi Business Overview
10.18.5 Sanofi Recent Developments
10.19 Geropharm
10.19.1 Geropharm Biosimilars Drug Basic Information
10.19.2 Geropharm Biosimilars Drug Product Overview
10.19.3 Geropharm Biosimilars Drug Product Market Performance
10.19.4 Geropharm Business Overview
10.19.5 Geropharm Recent Developments
10.20 Biocon
10.20.1 Biocon Biosimilars Drug Basic Information
10.20.2 Biocon Biosimilars Drug Product Overview
10.20.3 Biocon Biosimilars Drug Product Market Performance
10.20.4 Biocon Business Overview
10.20.5 Biocon Recent Developments
10.21 Wockhardt
10.21.1 Wockhardt Biosimilars Drug Basic Information
10.21.2 Wockhardt Biosimilars Drug Product Overview
10.21.3 Wockhardt Biosimilars Drug Product Market Performance
10.21.4 Wockhardt Business Overview
10.21.5 Wockhardt Recent Developments
11 BIOSIMILARS DRUG MARKET FORECAST BY REGION
11.1 Global Biosimilars Drug Market Size Forecast
11.2 Global Biosimilars Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biosimilars Drug Market Size Forecast by Country
11.2.3 Asia Pacific Biosimilars Drug Market Size Forecast by Region
11.2.4 South America Biosimilars Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Biosimilars Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Biosimilars Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Biosimilars Drug by Type (2025-2032)
12.1.2 Global Biosimilars Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Biosimilars Drug by Type (2025-2032)
12.2 Global Biosimilars Drug Market Forecast by Application (2025-2032)
12.2.1 Global Biosimilars Drug Sales (K MT) Forecast by Application
12.2.2 Global Biosimilars Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biosimilars Drug
1.2 Key Market Segments
1.2.1 Biosimilars Drug Segment by Type
1.2.2 Biosimilars Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOSIMILARS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biosimilars Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Biosimilars Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOSIMILARS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Biosimilars Drug Sales by Manufacturers (2019-2024)
3.2 Global Biosimilars Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biosimilars Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biosimilars Drug Sales Sites, Area Served, Product Type
3.6 Biosimilars Drug Market Competitive Situation and Trends
3.6.1 Biosimilars Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biosimilars Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOSIMILARS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Biosimilars Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOSIMILARS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOSIMILARS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biosimilars Drug Sales Market Share by Type (2019-2024)
6.3 Global Biosimilars Drug Market Size Market Share by Type (2019-2024)
6.4 Global Biosimilars Drug Price by Type (2019-2024)
7 BIOSIMILARS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biosimilars Drug Market Sales by Application (2019-2024)
7.3 Global Biosimilars Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Biosimilars Drug Sales Growth Rate by Application (2019-2024)
8 BIOSIMILARS DRUG MARKET CONSUMPTION BY REGION
8.1 Global Biosimilars Drug Sales by Region
8.1.1 Global Biosimilars Drug Sales by Region
8.1.2 Global Biosimilars Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Biosimilars Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biosimilars Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biosimilars Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biosimilars Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biosimilars Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 BIOSIMILARS DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Biosimilars Drug by Region (2019-2024)
9.2 Global Biosimilars Drug Revenue Market Share by Region (2019-2024)
9.3 Global Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Biosimilars Drug Production
9.4.1 North America Biosimilars Drug Production Growth Rate (2019-2024)
9.4.2 North America Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Biosimilars Drug Production
9.5.1 Europe Biosimilars Drug Production Growth Rate (2019-2024)
9.5.2 Europe Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Biosimilars Drug Production (2019-2024)
9.6.1 Japan Biosimilars Drug Production Growth Rate (2019-2024)
9.6.2 Japan Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Biosimilars Drug Production (2019-2024)
9.7.1 China Biosimilars Drug Production Growth Rate (2019-2024)
9.7.2 China Biosimilars Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Qilu Pharmaceutical
10.1.1 Qilu Pharmaceutical Biosimilars Drug Basic Information
10.1.2 Qilu Pharmaceutical Biosimilars Drug Product Overview
10.1.3 Qilu Pharmaceutical Biosimilars Drug Product Market Performance
10.1.4 Qilu Pharmaceutical Business Overview
10.1.5 Qilu Pharmaceutical Biosimilars Drug SWOT Analysis
10.1.6 Qilu Pharmaceutical Recent Developments
10.2 Bio-Thera
10.2.1 Bio-Thera Biosimilars Drug Basic Information
10.2.2 Bio-Thera Biosimilars Drug Product Overview
10.2.3 Bio-Thera Biosimilars Drug Product Market Performance
10.2.4 Bio-Thera Business Overview
10.2.5 Bio-Thera Biosimilars Drug SWOT Analysis
10.2.6 Bio-Thera Recent Developments
10.3 Zhejiang Hisun
10.3.1 Zhejiang Hisun Biosimilars Drug Basic Information
10.3.2 Zhejiang Hisun Biosimilars Drug Product Overview
10.3.3 Zhejiang Hisun Biosimilars Drug Product Market Performance
10.3.4 Zhejiang Hisun Biosimilars Drug SWOT Analysis
10.3.5 Zhejiang Hisun Business Overview
10.3.6 Zhejiang Hisun Recent Developments
10.4 Shanghai Henlius
10.4.1 Shanghai Henlius Biosimilars Drug Basic Information
10.4.2 Shanghai Henlius Biosimilars Drug Product Overview
10.4.3 Shanghai Henlius Biosimilars Drug Product Market Performance
10.4.4 Shanghai Henlius Business Overview
10.4.5 Shanghai Henlius Recent Developments
10.5 Innovent Biologics
10.5.1 Innovent Biologics Biosimilars Drug Basic Information
10.5.2 Innovent Biologics Biosimilars Drug Product Overview
10.5.3 Innovent Biologics Biosimilars Drug Product Market Performance
10.5.4 Innovent Biologics Business Overview
10.5.5 Innovent Biologics Recent Developments
10.6 Jiangsu Hengrui
10.6.1 Jiangsu Hengrui Biosimilars Drug Basic Information
10.6.2 Jiangsu Hengrui Biosimilars Drug Product Overview
10.6.3 Jiangsu Hengrui Biosimilars Drug Product Market Performance
10.6.4 Jiangsu Hengrui Business Overview
10.6.5 Jiangsu Hengrui Recent Developments
10.7 GanandLee
10.7.1 GanandLee Biosimilars Drug Basic Information
10.7.2 GanandLee Biosimilars Drug Product Overview
10.7.3 GanandLee Biosimilars Drug Product Market Performance
10.7.4 GanandLee Business Overview
10.7.5 GanandLee Recent Developments
10.8 Tonghua Dongbao
10.8.1 Tonghua Dongbao Biosimilars Drug Basic Information
10.8.2 Tonghua Dongbao Biosimilars Drug Product Overview
10.8.3 Tonghua Dongbao Biosimilars Drug Product Market Performance
10.8.4 Tonghua Dongbao Business Overview
10.8.5 Tonghua Dongbao Recent Developments
10.9 United Laboratory
10.9.1 United Laboratory Biosimilars Drug Basic Information
10.9.2 United Laboratory Biosimilars Drug Product Overview
10.9.3 United Laboratory Biosimilars Drug Product Market Performance
10.9.4 United Laboratory Business Overview
10.9.5 United Laboratory Recent Developments
10.10 3SBIO
10.10.1 3SBIO Biosimilars Drug Basic Information
10.10.2 3SBIO Biosimilars Drug Product Overview
10.10.3 3SBIO Biosimilars Drug Product Market Performance
10.10.4 3SBIO Business Overview
10.10.5 3SBIO Recent Developments
10.11 Luye Pharma
10.11.1 Luye Pharma Biosimilars Drug Basic Information
10.11.2 Luye Pharma Biosimilars Drug Product Overview
10.11.3 Luye Pharma Biosimilars Drug Product Market Performance
10.11.4 Luye Pharma Business Overview
10.11.5 Luye Pharma Recent Developments
10.12 Celltrion
10.12.1 Celltrion Biosimilars Drug Basic Information
10.12.2 Celltrion Biosimilars Drug Product Overview
10.12.3 Celltrion Biosimilars Drug Product Market Performance
10.12.4 Celltrion Business Overview
10.12.5 Celltrion Recent Developments
10.13 Pfizer
10.13.1 Pfizer Biosimilars Drug Basic Information
10.13.2 Pfizer Biosimilars Drug Product Overview
10.13.3 Pfizer Biosimilars Drug Product Market Performance
10.13.4 Pfizer Business Overview
10.13.5 Pfizer Recent Developments
10.14 Novartis
10.14.1 Novartis Biosimilars Drug Basic Information
10.14.2 Novartis Biosimilars Drug Product Overview
10.14.3 Novartis Biosimilars Drug Product Market Performance
10.14.4 Novartis Business Overview
10.14.5 Novartis Recent Developments
10.15 Dr Reddy’s
10.15.1 Dr Reddy’s Biosimilars Drug Basic Information
10.15.2 Dr Reddy’s Biosimilars Drug Product Overview
10.15.3 Dr Reddy’s Biosimilars Drug Product Market Performance
10.15.4 Dr Reddy’s Business Overview
10.15.5 Dr Reddy’s Recent Developments
10.16 Celgen Biopharma
10.16.1 Celgen Biopharma Biosimilars Drug Basic Information
10.16.2 Celgen Biopharma Biosimilars Drug Product Overview
10.16.3 Celgen Biopharma Biosimilars Drug Product Market Performance
10.16.4 Celgen Biopharma Business Overview
10.16.5 Celgen Biopharma Recent Developments
10.17 Eli Lilly
10.17.1 Eli Lilly Biosimilars Drug Basic Information
10.17.2 Eli Lilly Biosimilars Drug Product Overview
10.17.3 Eli Lilly Biosimilars Drug Product Market Performance
10.17.4 Eli Lilly Business Overview
10.17.5 Eli Lilly Recent Developments
10.18 Sanofi
10.18.1 Sanofi Biosimilars Drug Basic Information
10.18.2 Sanofi Biosimilars Drug Product Overview
10.18.3 Sanofi Biosimilars Drug Product Market Performance
10.18.4 Sanofi Business Overview
10.18.5 Sanofi Recent Developments
10.19 Geropharm
10.19.1 Geropharm Biosimilars Drug Basic Information
10.19.2 Geropharm Biosimilars Drug Product Overview
10.19.3 Geropharm Biosimilars Drug Product Market Performance
10.19.4 Geropharm Business Overview
10.19.5 Geropharm Recent Developments
10.20 Biocon
10.20.1 Biocon Biosimilars Drug Basic Information
10.20.2 Biocon Biosimilars Drug Product Overview
10.20.3 Biocon Biosimilars Drug Product Market Performance
10.20.4 Biocon Business Overview
10.20.5 Biocon Recent Developments
10.21 Wockhardt
10.21.1 Wockhardt Biosimilars Drug Basic Information
10.21.2 Wockhardt Biosimilars Drug Product Overview
10.21.3 Wockhardt Biosimilars Drug Product Market Performance
10.21.4 Wockhardt Business Overview
10.21.5 Wockhardt Recent Developments
11 BIOSIMILARS DRUG MARKET FORECAST BY REGION
11.1 Global Biosimilars Drug Market Size Forecast
11.2 Global Biosimilars Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biosimilars Drug Market Size Forecast by Country
11.2.3 Asia Pacific Biosimilars Drug Market Size Forecast by Region
11.2.4 South America Biosimilars Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Biosimilars Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Biosimilars Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Biosimilars Drug by Type (2025-2032)
12.1.2 Global Biosimilars Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Biosimilars Drug by Type (2025-2032)
12.2 Global Biosimilars Drug Market Forecast by Application (2025-2032)
12.2.1 Global Biosimilars Drug Sales (K MT) Forecast by Application
12.2.2 Global Biosimilars Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biosimilars Drug Market Size Comparison by Region (M USD)
Table 5. Global Biosimilars Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Biosimilars Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biosimilars Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biosimilars Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Drug as of 2022)
Table 10. Global Market Biosimilars Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biosimilars Drug Sales Sites and Area Served
Table 12. Manufacturers Biosimilars Drug Product Type
Table 13. Global Biosimilars Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biosimilars Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biosimilars Drug Market Challenges
Table 22. Global Biosimilars Drug Sales by Type (K MT)
Table 23. Global Biosimilars Drug Market Size by Type (M USD)
Table 24. Global Biosimilars Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Biosimilars Drug Sales Market Share by Type (2019-2024)
Table 26. Global Biosimilars Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Biosimilars Drug Market Size Share by Type (2019-2024)
Table 28. Global Biosimilars Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Biosimilars Drug Sales (K MT) by Application
Table 30. Global Biosimilars Drug Market Size by Application
Table 31. Global Biosimilars Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Biosimilars Drug Sales Market Share by Application (2019-2024)
Table 33. Global Biosimilars Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Biosimilars Drug Market Share by Application (2019-2024)
Table 35. Global Biosimilars Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Biosimilars Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Biosimilars Drug Sales Market Share by Region (2019-2024)
Table 38. North America Biosimilars Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Biosimilars Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Biosimilars Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Biosimilars Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Biosimilars Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Biosimilars Drug Production (K MT) by Region (2019-2024)
Table 44. Global Biosimilars Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Biosimilars Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Qilu Pharmaceutical Biosimilars Drug Basic Information
Table 52. Qilu Pharmaceutical Biosimilars Drug Product Overview
Table 53. Qilu Pharmaceutical Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Qilu Pharmaceutical Business Overview
Table 55. Qilu Pharmaceutical Biosimilars Drug SWOT Analysis
Table 56. Qilu Pharmaceutical Recent Developments
Table 57. Bio-Thera Biosimilars Drug Basic Information
Table 58. Bio-Thera Biosimilars Drug Product Overview
Table 59. Bio-Thera Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Bio-Thera Business Overview
Table 61. Bio-Thera Biosimilars Drug SWOT Analysis
Table 62. Bio-Thera Recent Developments
Table 63. Zhejiang Hisun Biosimilars Drug Basic Information
Table 64. Zhejiang Hisun Biosimilars Drug Product Overview
Table 65. Zhejiang Hisun Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Zhejiang Hisun Biosimilars Drug SWOT Analysis
Table 67. Zhejiang Hisun Business Overview
Table 68. Zhejiang Hisun Recent Developments
Table 69. Shanghai Henlius Biosimilars Drug Basic Information
Table 70. Shanghai Henlius Biosimilars Drug Product Overview
Table 71. Shanghai Henlius Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Shanghai Henlius Business Overview
Table 73. Shanghai Henlius Recent Developments
Table 74. Innovent Biologics Biosimilars Drug Basic Information
Table 75. Innovent Biologics Biosimilars Drug Product Overview
Table 76. Innovent Biologics Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Innovent Biologics Business Overview
Table 78. Innovent Biologics Recent Developments
Table 79. Jiangsu Hengrui Biosimilars Drug Basic Information
Table 80. Jiangsu Hengrui Biosimilars Drug Product Overview
Table 81. Jiangsu Hengrui Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Jiangsu Hengrui Business Overview
Table 83. Jiangsu Hengrui Recent Developments
Table 84. GanandLee Biosimilars Drug Basic Information
Table 85. GanandLee Biosimilars Drug Product Overview
Table 86. GanandLee Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. GanandLee Business Overview
Table 88. GanandLee Recent Developments
Table 89. Tonghua Dongbao Biosimilars Drug Basic Information
Table 90. Tonghua Dongbao Biosimilars Drug Product Overview
Table 91. Tonghua Dongbao Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Tonghua Dongbao Business Overview
Table 93. Tonghua Dongbao Recent Developments
Table 94. United Laboratory Biosimilars Drug Basic Information
Table 95. United Laboratory Biosimilars Drug Product Overview
Table 96. United Laboratory Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. United Laboratory Business Overview
Table 98. United Laboratory Recent Developments
Table 99. 3SBIO Biosimilars Drug Basic Information
Table 100. 3SBIO Biosimilars Drug Product Overview
Table 101. 3SBIO Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. 3SBIO Business Overview
Table 103. 3SBIO Recent Developments
Table 104. Luye Pharma Biosimilars Drug Basic Information
Table 105. Luye Pharma Biosimilars Drug Product Overview
Table 106. Luye Pharma Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Luye Pharma Business Overview
Table 108. Luye Pharma Recent Developments
Table 109. Celltrion Biosimilars Drug Basic Information
Table 110. Celltrion Biosimilars Drug Product Overview
Table 111. Celltrion Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Celltrion Business Overview
Table 113. Celltrion Recent Developments
Table 114. Pfizer Biosimilars Drug Basic Information
Table 115. Pfizer Biosimilars Drug Product Overview
Table 116. Pfizer Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Pfizer Business Overview
Table 118. Pfizer Recent Developments
Table 119. Novartis Biosimilars Drug Basic Information
Table 120. Novartis Biosimilars Drug Product Overview
Table 121. Novartis Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Novartis Business Overview
Table 123. Novartis Recent Developments
Table 124. Dr Reddy’s Biosimilars Drug Basic Information
Table 125. Dr Reddy’s Biosimilars Drug Product Overview
Table 126. Dr Reddy’s Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Dr Reddy’s Business Overview
Table 128. Dr Reddy’s Recent Developments
Table 129. Celgen Biopharma Biosimilars Drug Basic Information
Table 130. Celgen Biopharma Biosimilars Drug Product Overview
Table 131. Celgen Biopharma Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Celgen Biopharma Business Overview
Table 133. Celgen Biopharma Recent Developments
Table 134. Eli Lilly Biosimilars Drug Basic Information
Table 135. Eli Lilly Biosimilars Drug Product Overview
Table 136. Eli Lilly Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Eli Lilly Business Overview
Table 138. Eli Lilly Recent Developments
Table 139. Sanofi Biosimilars Drug Basic Information
Table 140. Sanofi Biosimilars Drug Product Overview
Table 141. Sanofi Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Sanofi Business Overview
Table 143. Sanofi Recent Developments
Table 144. Geropharm Biosimilars Drug Basic Information
Table 145. Geropharm Biosimilars Drug Product Overview
Table 146. Geropharm Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Geropharm Business Overview
Table 148. Geropharm Recent Developments
Table 149. Biocon Biosimilars Drug Basic Information
Table 150. Biocon Biosimilars Drug Product Overview
Table 151. Biocon Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Biocon Business Overview
Table 153. Biocon Recent Developments
Table 154. Wockhardt Biosimilars Drug Basic Information
Table 155. Wockhardt Biosimilars Drug Product Overview
Table 156. Wockhardt Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Wockhardt Business Overview
Table 158. Wockhardt Recent Developments
Table 159. Global Biosimilars Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 160. Global Biosimilars Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Biosimilars Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 162. North America Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Biosimilars Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 164. Europe Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Biosimilars Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 166. Asia Pacific Biosimilars Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Biosimilars Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 168. South America Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Biosimilars Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Biosimilars Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 172. Global Biosimilars Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Biosimilars Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 174. Global Biosimilars Drug Sales (K MT) Forecast by Application (2025-2032)
Table 175. Global Biosimilars Drug Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biosimilars Drug Market Size Comparison by Region (M USD)
Table 5. Global Biosimilars Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Biosimilars Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biosimilars Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biosimilars Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Drug as of 2022)
Table 10. Global Market Biosimilars Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biosimilars Drug Sales Sites and Area Served
Table 12. Manufacturers Biosimilars Drug Product Type
Table 13. Global Biosimilars Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biosimilars Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biosimilars Drug Market Challenges
Table 22. Global Biosimilars Drug Sales by Type (K MT)
Table 23. Global Biosimilars Drug Market Size by Type (M USD)
Table 24. Global Biosimilars Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Biosimilars Drug Sales Market Share by Type (2019-2024)
Table 26. Global Biosimilars Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Biosimilars Drug Market Size Share by Type (2019-2024)
Table 28. Global Biosimilars Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Biosimilars Drug Sales (K MT) by Application
Table 30. Global Biosimilars Drug Market Size by Application
Table 31. Global Biosimilars Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Biosimilars Drug Sales Market Share by Application (2019-2024)
Table 33. Global Biosimilars Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Biosimilars Drug Market Share by Application (2019-2024)
Table 35. Global Biosimilars Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Biosimilars Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Biosimilars Drug Sales Market Share by Region (2019-2024)
Table 38. North America Biosimilars Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Biosimilars Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Biosimilars Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Biosimilars Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Biosimilars Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Biosimilars Drug Production (K MT) by Region (2019-2024)
Table 44. Global Biosimilars Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Biosimilars Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Biosimilars Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Qilu Pharmaceutical Biosimilars Drug Basic Information
Table 52. Qilu Pharmaceutical Biosimilars Drug Product Overview
Table 53. Qilu Pharmaceutical Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Qilu Pharmaceutical Business Overview
Table 55. Qilu Pharmaceutical Biosimilars Drug SWOT Analysis
Table 56. Qilu Pharmaceutical Recent Developments
Table 57. Bio-Thera Biosimilars Drug Basic Information
Table 58. Bio-Thera Biosimilars Drug Product Overview
Table 59. Bio-Thera Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Bio-Thera Business Overview
Table 61. Bio-Thera Biosimilars Drug SWOT Analysis
Table 62. Bio-Thera Recent Developments
Table 63. Zhejiang Hisun Biosimilars Drug Basic Information
Table 64. Zhejiang Hisun Biosimilars Drug Product Overview
Table 65. Zhejiang Hisun Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Zhejiang Hisun Biosimilars Drug SWOT Analysis
Table 67. Zhejiang Hisun Business Overview
Table 68. Zhejiang Hisun Recent Developments
Table 69. Shanghai Henlius Biosimilars Drug Basic Information
Table 70. Shanghai Henlius Biosimilars Drug Product Overview
Table 71. Shanghai Henlius Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Shanghai Henlius Business Overview
Table 73. Shanghai Henlius Recent Developments
Table 74. Innovent Biologics Biosimilars Drug Basic Information
Table 75. Innovent Biologics Biosimilars Drug Product Overview
Table 76. Innovent Biologics Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Innovent Biologics Business Overview
Table 78. Innovent Biologics Recent Developments
Table 79. Jiangsu Hengrui Biosimilars Drug Basic Information
Table 80. Jiangsu Hengrui Biosimilars Drug Product Overview
Table 81. Jiangsu Hengrui Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Jiangsu Hengrui Business Overview
Table 83. Jiangsu Hengrui Recent Developments
Table 84. GanandLee Biosimilars Drug Basic Information
Table 85. GanandLee Biosimilars Drug Product Overview
Table 86. GanandLee Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. GanandLee Business Overview
Table 88. GanandLee Recent Developments
Table 89. Tonghua Dongbao Biosimilars Drug Basic Information
Table 90. Tonghua Dongbao Biosimilars Drug Product Overview
Table 91. Tonghua Dongbao Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Tonghua Dongbao Business Overview
Table 93. Tonghua Dongbao Recent Developments
Table 94. United Laboratory Biosimilars Drug Basic Information
Table 95. United Laboratory Biosimilars Drug Product Overview
Table 96. United Laboratory Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. United Laboratory Business Overview
Table 98. United Laboratory Recent Developments
Table 99. 3SBIO Biosimilars Drug Basic Information
Table 100. 3SBIO Biosimilars Drug Product Overview
Table 101. 3SBIO Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. 3SBIO Business Overview
Table 103. 3SBIO Recent Developments
Table 104. Luye Pharma Biosimilars Drug Basic Information
Table 105. Luye Pharma Biosimilars Drug Product Overview
Table 106. Luye Pharma Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Luye Pharma Business Overview
Table 108. Luye Pharma Recent Developments
Table 109. Celltrion Biosimilars Drug Basic Information
Table 110. Celltrion Biosimilars Drug Product Overview
Table 111. Celltrion Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Celltrion Business Overview
Table 113. Celltrion Recent Developments
Table 114. Pfizer Biosimilars Drug Basic Information
Table 115. Pfizer Biosimilars Drug Product Overview
Table 116. Pfizer Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Pfizer Business Overview
Table 118. Pfizer Recent Developments
Table 119. Novartis Biosimilars Drug Basic Information
Table 120. Novartis Biosimilars Drug Product Overview
Table 121. Novartis Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Novartis Business Overview
Table 123. Novartis Recent Developments
Table 124. Dr Reddy’s Biosimilars Drug Basic Information
Table 125. Dr Reddy’s Biosimilars Drug Product Overview
Table 126. Dr Reddy’s Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Dr Reddy’s Business Overview
Table 128. Dr Reddy’s Recent Developments
Table 129. Celgen Biopharma Biosimilars Drug Basic Information
Table 130. Celgen Biopharma Biosimilars Drug Product Overview
Table 131. Celgen Biopharma Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Celgen Biopharma Business Overview
Table 133. Celgen Biopharma Recent Developments
Table 134. Eli Lilly Biosimilars Drug Basic Information
Table 135. Eli Lilly Biosimilars Drug Product Overview
Table 136. Eli Lilly Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Eli Lilly Business Overview
Table 138. Eli Lilly Recent Developments
Table 139. Sanofi Biosimilars Drug Basic Information
Table 140. Sanofi Biosimilars Drug Product Overview
Table 141. Sanofi Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Sanofi Business Overview
Table 143. Sanofi Recent Developments
Table 144. Geropharm Biosimilars Drug Basic Information
Table 145. Geropharm Biosimilars Drug Product Overview
Table 146. Geropharm Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Geropharm Business Overview
Table 148. Geropharm Recent Developments
Table 149. Biocon Biosimilars Drug Basic Information
Table 150. Biocon Biosimilars Drug Product Overview
Table 151. Biocon Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Biocon Business Overview
Table 153. Biocon Recent Developments
Table 154. Wockhardt Biosimilars Drug Basic Information
Table 155. Wockhardt Biosimilars Drug Product Overview
Table 156. Wockhardt Biosimilars Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Wockhardt Business Overview
Table 158. Wockhardt Recent Developments
Table 159. Global Biosimilars Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 160. Global Biosimilars Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Biosimilars Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 162. North America Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Biosimilars Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 164. Europe Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Biosimilars Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 166. Asia Pacific Biosimilars Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Biosimilars Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 168. South America Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Biosimilars Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Biosimilars Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Biosimilars Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 172. Global Biosimilars Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Biosimilars Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 174. Global Biosimilars Drug Sales (K MT) Forecast by Application (2025-2032)
Table 175. Global Biosimilars Drug Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biosimilars Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biosimilars Drug Market Size (M USD), 2019-2032
Figure 5. Global Biosimilars Drug Market Size (M USD) (2019-2032)
Figure 6. Global Biosimilars Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biosimilars Drug Market Size by Country (M USD)
Figure 11. Biosimilars Drug Sales Share by Manufacturers in 2023
Figure 12. Global Biosimilars Drug Revenue Share by Manufacturers in 2023
Figure 13. Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biosimilars Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biosimilars Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biosimilars Drug Market Share by Type
Figure 18. Sales Market Share of Biosimilars Drug by Type (2019-2024)
Figure 19. Sales Market Share of Biosimilars Drug by Type in 2023
Figure 20. Market Size Share of Biosimilars Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Biosimilars Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biosimilars Drug Market Share by Application
Figure 24. Global Biosimilars Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Biosimilars Drug Sales Market Share by Application in 2023
Figure 26. Global Biosimilars Drug Market Share by Application (2019-2024)
Figure 27. Global Biosimilars Drug Market Share by Application in 2023
Figure 28. Global Biosimilars Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biosimilars Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Biosimilars Drug Sales Market Share by Country in 2023
Figure 32. U.S. Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Biosimilars Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Biosimilars Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Biosimilars Drug Sales Market Share by Country in 2023
Figure 37. Germany Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Biosimilars Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Biosimilars Drug Sales Market Share by Region in 2023
Figure 44. China Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Biosimilars Drug Sales and Growth Rate (K MT)
Figure 50. South America Biosimilars Drug Sales Market Share by Country in 2023
Figure 51. Brazil Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Biosimilars Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Biosimilars Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Biosimilars Drug Production Market Share by Region (2019-2024)
Figure 62. North America Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Biosimilars Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Biosimilars Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Biosimilars Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Biosimilars Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Biosimilars Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Biosimilars Drug Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Biosimilars Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biosimilars Drug Market Size (M USD), 2019-2032
Figure 5. Global Biosimilars Drug Market Size (M USD) (2019-2032)
Figure 6. Global Biosimilars Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biosimilars Drug Market Size by Country (M USD)
Figure 11. Biosimilars Drug Sales Share by Manufacturers in 2023
Figure 12. Global Biosimilars Drug Revenue Share by Manufacturers in 2023
Figure 13. Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biosimilars Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biosimilars Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biosimilars Drug Market Share by Type
Figure 18. Sales Market Share of Biosimilars Drug by Type (2019-2024)
Figure 19. Sales Market Share of Biosimilars Drug by Type in 2023
Figure 20. Market Size Share of Biosimilars Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Biosimilars Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biosimilars Drug Market Share by Application
Figure 24. Global Biosimilars Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Biosimilars Drug Sales Market Share by Application in 2023
Figure 26. Global Biosimilars Drug Market Share by Application (2019-2024)
Figure 27. Global Biosimilars Drug Market Share by Application in 2023
Figure 28. Global Biosimilars Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biosimilars Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Biosimilars Drug Sales Market Share by Country in 2023
Figure 32. U.S. Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Biosimilars Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Biosimilars Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Biosimilars Drug Sales Market Share by Country in 2023
Figure 37. Germany Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Biosimilars Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Biosimilars Drug Sales Market Share by Region in 2023
Figure 44. China Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Biosimilars Drug Sales and Growth Rate (K MT)
Figure 50. South America Biosimilars Drug Sales Market Share by Country in 2023
Figure 51. Brazil Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Biosimilars Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Biosimilars Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Biosimilars Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Biosimilars Drug Production Market Share by Region (2019-2024)
Figure 62. North America Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Biosimilars Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Biosimilars Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Biosimilars Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Biosimilars Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Biosimilars Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Biosimilars Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Biosimilars Drug Market Share Forecast by Application (2025-2032)
